Related references
Note: Only part of the references are listed.Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Sheng F. Cai et al.
MOLECULAR CELL (2015)
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
Jae-Seok Roe et al.
MOLECULAR CELL (2015)
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert et al.
NATURE (2015)
BET inhibitor resistance emerges from leukaemia stem cells
Chun Yew Fong et al.
NATURE (2015)
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Junwei Shi et al.
NATURE BIOTECHNOLOGY (2015)
What are super-enhancers?
Sebastian Pott et al.
NATURE GENETICS (2015)
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Vincent-Philippe Lavallee et al.
NATURE GENETICS (2015)
DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
Chun-Wei Chen et al.
NATURE MEDICINE (2015)
Getting up to speed with transcription elongation by RNA polymerase II
Iris Jonkers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Results of Phase 2 Randomized Study of Low-Dose Decitabine With or Without Valproic Acid in Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia
Jean-Pierre Issa et al.
CANCER (2015)
BET-bromodomain inhibitor OTX015 shows clinically meaningful activity at nontoxic doses: interim results of an ongoing phase I trial in hematologic malignancies
Patrice E. Herait et al.
CANCER RESEARCH (2014)
Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905
Thomas Prebet et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
M. A. Dawson et al.
LEUKEMIA (2014)
The emerging roles of DOT1L in leukemia and normal development
C. M. McLean et al.
LEUKEMIA (2014)
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
S. M. Sarkaria et al.
LEUKEMIA (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4
Ryan A. Henry et al.
BIOCHEMISTRY (2013)
Recent progress toward epigenetic therapies: the example of mixed lineage leukemia
Tobias Neff et al.
BLOOD (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Transcriptional elongation checkpoint control in development and disease
Edwin Smith et al.
GENES & DEVELOPMENT (2013)
Measuring and Managing Ratio Compression for Accurate iTRAQ/TMT Quantification
Mikhail M. Savitski et al.
JOURNAL OF PROTEOME RESEARCH (2013)
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Liuqing Yang et al.
NATURE (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
High-Resolution Enabled TMT 8-plexing
Thilo Werner et al.
ANALYTICAL CHEMISTRY (2012)
GenomicTools: a computational platform for developing high-throughput analytics in genomics
Aristotelis Tsirigos et al.
BIOINFORMATICS (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Jolanta Grembecka et al.
NATURE CHEMICAL BIOLOGY (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting Epigenetic Readers in Cancer
Mark A. Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inferring direct DNA binding from ChIP-seq
Timothy L. Bailey et al.
NUCLEIC ACIDS RESEARCH (2012)
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Wenyu Yu et al.
NATURE COMMUNICATIONS (2012)
Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins
Gary LeRoy et al.
GENOME BIOLOGY (2012)
Delayed Fragmentation and Optimized Isolation Width Settings for Improvement of Protein Identification and Accuracy of Isobaric Mass Tag Quantification on Orbitrap-Type Mass Spectrometers
Mikhail M. Savitski et al.
ANALYTICAL CHEMISTRY (2011)
Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
Stephanie Y. Jo et al.
BLOOD (2011)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
The diverse functions of Dot1 and H3K79 methylation
Anh Tram Nguyen et al.
GENES & DEVELOPMENT (2011)
Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells
U. Kruse et al.
LEUKEMIA (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation
Rui Zhao et al.
NATURE CELL BIOLOGY (2011)
Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
Debabrata Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
ROAST: rotation gene set tests for complex microarray experiments
Di Wu et al.
BIOINFORMATICS (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription
Akihiko Yokoyama et al.
CANCER CELL (2010)
The Language of Histone Crosstalk
Jung-Shin Lee et al.
CELL (2010)
Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)
Man Mohan et al.
GENES & DEVELOPMENT (2010)
Targeted Data Acquisition for Improved Reproducibility and Robustness of Proteomic Mass Spectrometry Assays
Mikhail M. Savitski et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2010)
AFF4, a Component of the ELL/P-TEFb Elongation Complex and a Shared Subunit of MLL Chimeras, Can Link Transcription Elongation to Leukemia
Chengqi Lin et al.
MOLECULAR CELL (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis
Man Mohan et al.
NATURE REVIEWS CANCER (2010)
Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia
Dorothee Mueller et al.
PLOS BIOLOGY (2009)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
MII has a critical role in fetal and adult hematopoietic stem cell self-renewal
Kathryn A. McMahon et al.
CELL STEM CELL (2007)
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors
Craig D. Jude et al.
CELL STEM CELL (2007)
The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling
Emmanuelle Bitoun et al.
HUMAN MOLECULAR GENETICS (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia
DB Shankar et al.
CANCER CELL (2005)
Share Paper
